Download PDF
Semin Plast Surg 2006; 20(3): 169-179
DOI: 10.1055/s-2006-949120
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Pigmented Lesions in Children

Julie E. Russak1 , James G.H Dinulos1
  • 1Section of Dermatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
Further Information

Publication History

Publication Date:
18 September 2006 (online)

    Permissions and Reprints

ABSTRACT

Pigmented lesions in childhood can pose significant diagnostic and therapeutic challenges. This article examines the most common pigmented lesions encountered in childhood. Special emphasis is placed on the diagnosis and management of congenital melanocytic nevi, acquired melanocytic nevi, clonal nevi, halo nevi, atypical melanocytic nevi, Spitz nevi, recurrent nevi, childhood melanoma, blue nevi, speckled lentiginous nevi, and other melanocytic nevi such as nevus of Ota and nevus of Ito. Proper diagnosis and an understanding of the natural history of pigmented lesions in children are essential for successful outcomes.

KEYWORDS

Pigmented nevus - pediatric - Spitz nevus - congenital nevus - melanoma

REFERENCES

  • 1 Gilchrest B A, Fitzpatrick T B, Anderson R R, Parrish J A. Localization of melanin pigmentation in the skin with Wood's lamp.  Br J Dermatol. 1977;  96 245-248
    CrossrefPubMedGoogle Scholar
  • 2 Borbola K, Banfalvi T, Fejos Z et al.. Etiologic factors of malignant melanoma in young adults.  Orv Hetil. 2005;  146 1481-1487
    PubMedGoogle Scholar
  • 3 Friedman R J, Rigel D S, Silverman M K, Kopf A W, Vossaert K A. Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin.  CA Cancer J Clin. 1991;  41 201-226
    PubMedGoogle Scholar
  • 4 Soyer H P, Argenziano G, Chimenti S, Ruocco V. Dermoscopy of pigmented skin lesions.  Eur J Dermatol. 2001;  11 270-276
    PubMedGoogle Scholar
  • 5 Rigel D S. Cancer of the Skin. Philadelphia, PA; Saunders 2005
    Google Scholar
  • 6 Argenziano G, Fabbrocini G, Carli P, De Giorgi V, Sammarco E, Delfino M. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis.  Arch Dermatol. 1998;  134 1563-1570
    CrossrefPubMedGoogle Scholar
  • 7 Nachbar F, Stolz W, Merkle T et al.. The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions.  J Am Acad Dermatol. 1994;  30 551-559
    CrossrefPubMedGoogle Scholar
  • 8 Piccolo D, Ferrari A, Peris K, Diadone R, Ruggeri B, Chimenti S. Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer-aided diagnosis of 341 pigmented skin lesions: a comparative study.  Br J Dermatol. 2002;  147 481-486
    CrossrefPubMedGoogle Scholar
  • 9 Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy.  Lancet Oncol. 2002;  3 159-165
    CrossrefPubMedGoogle Scholar
  • 10 Cramer S F. The origin of epidermal melanocytes. Implications for the histogenesis of nevi and melanomas.  Arch Pathol Lab Med. 1991;  115 115-119
    PubMedGoogle Scholar
  • 11 Kincannon J, Boutzale C. The physiology of pigmented nevi.  Pediatrics. 1999;  104(4 Pt 2) 1042-1045
    PubMedGoogle Scholar
  • 12 Gontier E, Cario-Andre M, Vergnes P, Bizik J, Surleve-Bazeille J E, Taieb A. The ‘Abtropfung phenomenon’ revisited: dermal nevus cells from congenital nevi cannot activate matrix metalloproteinase 2 (MMP-2).  Pigment Cell Res. 2003;  16 366-373
    CrossrefPubMedGoogle Scholar
  • 13 Hoffman R M. The pluripotency of hair follicle stem cells.  Cell Cycle. 2006;  5 232-233
    PubMedGoogle Scholar
  • 14 Bartosik J, Wulf H C, Kobayasi T. Melanin and melanosome complexes in long standing stable vitiligo-an ultrastructural study.  Eur J Dermatol. 1998;  8 95-97
    PubMedGoogle Scholar
  • 15 Machado Filho C D, Almeida F A, Proto R S, Landman G. Vitiligo: analysis of grafting versus curettage alone, using melanocyte morphology and reverse transcriptase polymerase chain reaction for tyrosinase mRNA.  Sao Paulo Med J. 2005;  123 187-191
    PubMedGoogle Scholar
  • 16 Tannous Z S, Mihm Jr M C, Sober A J, Duncan L M. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management.  J Am Acad Dermatol. 2005;  52 197-203
    CrossrefPubMedGoogle Scholar
  • 17 Harrison S L, MacKie R M, MacLennan R. Development of melanocytic nevi in the first three years of life.  J Natl Cancer Inst. 2000;  92 1436-1438
    PubMedGoogle Scholar
  • 18 Valiukeviciene S, Miseviciene I, Gollnick H. The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania.  Arch Dermatol. 2005;  141 579-586
    CrossrefPubMedGoogle Scholar
  • 19 Brodell R, Sims D M, Zaim M T. Natural history of melanocytic nevi.  Am Fam Physician. 1988;  38 93-101
    PubMedGoogle Scholar
  • 20 Titus-Ernstoff L, Perry A E, Spencer S K, Gibson J J, Cole B F, Ernstoff M S. Pigmentary characteristics and moles in relation to melanoma risk.  Int J Cancer. 2005;  116 144-149
    CrossrefPubMedGoogle Scholar
  • 21 Krengel S. Nevogenesis-new thoughts regarding a classical problem.  Am J Dermatopathol. 2005;  27 456-465
    CrossrefPubMedGoogle Scholar
  • 22 Enta T, Kwan T Y. Melanocytic nevi in sun-protected Canadian Hutterite children.  Arch Dermatol. 1998;  134 379-381
    CrossrefPubMedGoogle Scholar
  • 23 Garbe C, Buttner P, Weiss J et al.. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.  J Invest Dermatol. 1994;  102 700-705
    CrossrefPubMedGoogle Scholar
  • 24 Harrison S L, MacLennan R, Speare R, Wronski I. Sun exposure and melanocytic naevi in young Australian children.  Lancet. 1994;  344 1529-1532
    CrossrefPubMedGoogle Scholar
  • 25 Stierner U. Melanocytes, moles and melanoma-a study on UV effects.  Acta Derm Venereol Suppl (Stockh). 1991;  168 1-31
    PubMedGoogle Scholar
  • 26 Diffey B L. Sunscreens and melanoma: the future looks bright.  Br J Dermatol. 2005;  153 378-381
    CrossrefPubMedGoogle Scholar
  • 27 Christensen D. Data still cloudy on association between sunscreen use and melanoma risk.  J Natl Cancer Inst. 2003;  95 932-933
    PubMedGoogle Scholar
  • 28 Rigel D S. The effect of sunscreen on melanoma risk.  Dermatol Clin. 2002;  20 601-606
    PubMedGoogle Scholar
  • 29 Bittencourt F V, Marghoob A A, Kopf A W, Koenig K L, Bart R S. Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis.  Pediatrics. 2000;  106 736-741
    CrossrefPubMedGoogle Scholar
  • 30 Kopf A W, Bart R S, Hennessey P. Congenital nevocytic nevi and malignant melanomas.  J Am Acad Dermatol. 1979;  1 123-130
    CrossrefPubMedGoogle Scholar
  • 31 Pappo A S. Melanoma in children and adolescents.  Eur J Cancer. 2003;  39 2651-2661
    CrossrefPubMedGoogle Scholar
  • 32 Rigel D S, Friedman R J, Kopf A W, Rogers G S, Heilman E R. Precursors of malignant melanoma. Problems in computing the risk of malignant melanoma arising in dysplastic and congenital nevocytic nevi.  Dermatol Clin. 1985;  3 361-365
    PubMedGoogle Scholar
  • 33 Egan C L, Oliveria S A, Elenitsas R, Hanson J, Halpern A C. Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients.  J Am Acad Dermatol. 1998;  39 923-932
    CrossrefPubMedGoogle Scholar
  • 34 Silverberg N B. Update on malignant melanoma in children.  Cutis. 2001;  67 393-396
    PubMedGoogle Scholar
  • 35 Alper J C, Holmes L B. The incidence and significance of birthmarks in a cohort of 4,641 newborns.  Pediatr Dermatol. 1983;  1 58-68
    CrossrefPubMedGoogle Scholar
  • 36 Streams B N, Lio P A, Mihm M C, Sober A J. A nonepidermal, primary malignant melanoma arising in a giant congenital melanocytic nevus 40 years after partial surgical removal.  J Am Acad Dermatol. 2004;  50 789-792
    CrossrefPubMedGoogle Scholar
  • 37 Rhodes A R, Wood W C, Sober A J, Mihm Jr M C. Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus.  Plast Reconstr Surg. 1981;  67 782-790
    PubMedGoogle Scholar
  • 38 Hale E K, Stein J, Ben-Porat L et al.. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi-results from the NYU-LCMN registry.  Br J Dermatol. 2005;  152 512-517
    CrossrefPubMedGoogle Scholar
  • 39 DeDavid M, Orlow S J, Provost N et al.. A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature.  J Am Acad Dermatol. 1997;  36(3 Pt 1) 409-416
    CrossrefPubMedGoogle Scholar
  • 40 Zaal L H, Mooi W J, Sillevis Smitt J H, van der Horst C M. Classification of congenital melanocytic naevi and malignant transformation: a review of the literature.  Br J Plast Surg. 2004;  57 707-719
    CrossrefPubMedGoogle Scholar
  • 41 Cunningham B B, Gigler V, Wang K et al.. General anesthesia for pediatric dermatologic procedures: risks and complication.  Arch Dermatol. 2005;  141 573-576
    CrossrefPubMedGoogle Scholar
  • 42 Arneja J S, Gosain A K. Giant congenital melanocytic nevi of the trunk and an algorithm for treatment.  J Craniofac Surg. 2005;  16 886-893
    CrossrefPubMedGoogle Scholar
  • 43 Ostertag J U, Quaedvlieg P J, Kerckhoffs F E et al.. Congenital naevi treated with erbium:YAG laser (Derma K) resurfacing in neonates: clinical results and review of the literature.  Br J Dermatol. 2006;  154 889-895
    CrossrefPubMedGoogle Scholar
  • 44 Foster R D, Williams M L, Barkovich A J, Hoffman W Y, Mathes S J, Frieden I J. Giant congenital melanocytic nevi: the significance of neurocutaneous melanosis in neurologically asymptomatic children.  Plast Reconstr Surg. 2001;  107 933-941
    PubMedGoogle Scholar
  • 45 Strungs I. Common and uncommon variants of melanocytic naevi.  Pathology. 2004;  36 396-403
    CrossrefPubMedGoogle Scholar
  • 46 Ball N J, Golitz L E. Melanocytic nevi with focal atypical epithelioid cell components: a review of seventy-three cases.  J Am Acad Dermatol. 1994;  30(5 Pt 1) 724-729
    PubMedGoogle Scholar
  • 47 Huynh P M, Glusac E J, Bolognia J L. The clinical appearance of clonal nevi (inverted type A nevi).  Int J Dermatol. 2004;  43 882-885
    CrossrefPubMedGoogle Scholar
  • 48 Bolognia J L, Lin A, Shapiro P E. The significance of eccentric foci of hyperpigmentation (‘small dark dots’) within melanocytic nevi. Analysis of 59 cases.  Arch Dermatol. 1994;  130 1013-1017
    CrossrefPubMedGoogle Scholar
  • 49 Herd R M, Hunter J A. Familial halo naevi.  Clin Exp Dermatol. 1998;  23 68-69
    CrossrefPubMedGoogle Scholar
  • 50 Gordeladze A S, Pavlova T A. Multiple halo nevi: their differential diagnosis from malignant melanoma.  Arkh Patol. 1990;  52 66-69
    PubMedGoogle Scholar
  • 51 Musette P, Bachelez H, Flageul B et al.. Immune-mediated destruction of melanocytes in halo nevi is associated with the local expansion of a limited number of T cell clones.  J Immunol. 1999;  162 1789-1794
    PubMedGoogle Scholar
  • 52 Lerner A B, Kirkwood J M. Vitiligo and melanoma: can genetically abnormal melanocytes result in both vitiligo and melanoma within a single family?.  J Am Acad Dermatol. 1984;  11(4 Pt 1) 696-701
    PubMedGoogle Scholar
  • 53 Albert D M, Todes-Taylor N, Wagoner M, Nordlund J J, Lerner A B. Vitiligo or halo nevi occurring in two patients with choroidal melanoma.  Arch Dermatol. 1982;  118 34-36
    CrossrefPubMedGoogle Scholar
  • 54 Weaver P C. The black cancer-malignant melanoma.  Nurs Times. 1976;  72 582-584
    PubMedGoogle Scholar
  • 55 Munro D D. Multiple active junctional naevi with family history of malignant melanoma.  Proc R Soc Med. 1974;  67 594-595
    PubMedGoogle Scholar
  • 56 Clark Jr W H, Reimer R R, Greene M, Ainsworth A M, Mastrangelo M J. Origin of familial malignant melanomas from heritable melanocytic lesions. ‘The B-K mole syndrome’.  Arch Dermatol. 1978;  114 732-738
    CrossrefPubMedGoogle Scholar
  • 57 Lynch H T, Fusaro R M, Danes B S, Kimberling W J, Lynch J F. A review of hereditary malignant melanoma including biomarkers in familial atypical multiple mole melanoma syndrome.  Cancer Genet Cytogenet. 1983;  8 325-358
    CrossrefPubMedGoogle Scholar
  • 58 Greene M H, Clark Jr W H, Tucker M A et al.. Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature.  Lancet. 1980;  2 1024
    PubMedGoogle Scholar
  • 59 Kang S, Barnhill R L, Mihm Jr M C, Fitzpatrick T B, Sober A J. Melanoma risk in individuals with clinically atypical nevi.  Arch Dermatol. 1994;  130 999-1001
    CrossrefPubMedGoogle Scholar
  • 60 Naeyaert J M, Brochez L. Clinical practice. Dysplastic nevi.  N Engl J Med. 2003;  349 2233-2240
    CrossrefPubMedGoogle Scholar
  • 61 Bonerandi J J, Grob J J. Melanoma and its risk factors. Epidemiology and consequences in detection and prevention.  Ann Dermatol Venereol. 1989;  116 411-417
    PubMedGoogle Scholar
  • 62 Steijlen P M, Bergman W, Hermans J, Scheffer E, Van Vloten W A, Ruiter D J. The efficacy of histopathological criteria required for diagnosing dysplastic naevi.  Histopathology. 1988;  12 289-300
    PubMedGoogle Scholar
  • 63 Ferrone C R, Ben Porat L, Panageas K S et al.. Clinicopathological features of and risk factors for multiple primary melanomas.  JAMA. 2005;  294 1647-1654
    CrossrefPubMedGoogle Scholar
  • 64 Hammer H, Toth-Molnar E, Olah J, Dobozy A. Connection between uveal melanoma and dysplastic naevus syndrome.  Magy Onkol. 2005;  49 15-18
    PubMedGoogle Scholar
  • 65 Halpern A C, Guerry D T, Elder D E et al.. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.  Arch Dermatol. 1991;  127 995-999
    CrossrefPubMedGoogle Scholar
  • 66 Marghoob A A, Slade J, Kopf A W, Salopek T G, Rigel D S, Bart R S. Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical-mole syndrome: a case-control study.  Br J Dermatol. 1996;  135 704-711
    CrossrefPubMedGoogle Scholar
  • 67 Elder D E. Precursors to melanoma and their mimics: nevi of special sites.  Mod Pathol. 2006;  19(suppl 2) S4-20
    CrossrefPubMedGoogle Scholar
  • 68 Rivers J K, Cockerell C J, McBride A, Kopf A W. Quantification of histologic features of dysplastic nevi.  Am J Dermatopathol. 1990;  12 42-50
    PubMedGoogle Scholar
  • 69 Langer K, Rappersberger K, Steiner A, Konrad K, Wolff K. The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi.  Arch Dermatol Res. 1990;  282 353-362
    CrossrefPubMedGoogle Scholar
  • 70 Hussein M R, Roggero E, Sudilovsky E C, Tuthill R J, Wood G S, Sudilovsky O. Alterations of mismatch repair protein expression in benign melanocytic nevi, melanocytic dysplastic nevi, and cutaneous malignant melanomas.  Am J Dermatopathol. 2001;  23 308-314
    CrossrefPubMedGoogle Scholar
  • 71 Tucker M A, Goldstein A M. Melanoma etiology: where are we?.  Oncogene. 2003;  22 3042-3052
    CrossrefPubMedGoogle Scholar
  • 72 Rigel D S, Friedman R J. The management of patients with dysplastic and congenital nevi.  Dermatol Clin. 1985;  3 251-255
    PubMedGoogle Scholar
  • 73 Marghoob A A, Kopf A W, Rigel D S et al.. Risk of cutaneous malignant melanoma in patients with ‘classic’ atypical-mole syndrome. A case-control study.  Arch Dermatol. 1994;  130 993-998
    CrossrefPubMedGoogle Scholar
  • 74 Tiersten A D, Grin C M, Kopf A W et al.. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome.  J Dermatol Surg Oncol. 1991;  17 44-48
    PubMedGoogle Scholar
  • 75 Ko C B, Walton S, Wyatt E H, Bury H P. Spitz nevus.  Int J Dermatol. 1993;  32 354-357
    PubMedGoogle Scholar
  • 76 Morgan C J, Nyak N, Cooper A, Pees B, Friedmann P S. Multiple Spitz naevi: a report of both variants with clinical and histopathological correlation.  Clin Exp Dermatol. 2006;  31 368-371
    CrossrefPubMedGoogle Scholar
  • 77 Calista D. Spitz naevus arising within congenital naevus spilus.  J Eur Acad Dermatol Venereol. 2005;  19 137-138
    PubMedGoogle Scholar
  • 78 Kapur P, Selim M A, Roy L C, Yegappan M, Weinberg A G, Hoang M P. Spitz nevi and atypical Spitz nevi tumors: a histologic and immunohistochemical analysis.  Mod Pathol. 2005;  18 197-204
    CrossrefPubMedGoogle Scholar
  • 79 Gill M, Cohen J, Renwick N, Mones J M, Silvers D N, Celebi J T. Genetic similarities between Spitz nevus and Spitzoid melanoma in children.  Cancer. 2004;  101 2636-2640
    CrossrefPubMedGoogle Scholar
  • 80 Murphy M E, Boyer J D, Stashower M E, Zitelli J A. The surgical management of Spitz nevi.  Dermatol Surg. 2002;  28 1065-1069 discussion 1069
    CrossrefPubMedGoogle Scholar
  • 81 Park H K, Leonard D D, Arrington III J H, Lund H Z. Recurrent melanocytic nevi: clinical and histologic review of 175 cases.  J Am Acad Dermatol. 1987;  17 285-292
    PubMedGoogle Scholar
  • 82 Sohn S, Kim S, Kang W H. Recurrent pigmented macules after q-switched alexandrite laser treatment of congenital melanocytic nevus.  Dermatol Surg. 2004;  30 898-907
    CrossrefPubMedGoogle Scholar
  • 83 Hoang M P, Prieto V G, Burchette J L, Shea C R. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation.  J Cutan Pathol. 2001;  28 400-406
    CrossrefPubMedGoogle Scholar
  • 84 Patterson W M, Lefkowitz A, Schwartz R A, Lambert W C, Rao B K. Melanoma in children.  Cutis. 2000;  65 269-272, 275
    PubMedGoogle Scholar
  • 85 Ferrari A, Bono A, Baldi M et al.. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution.  Pediatrics. 2005;  115 649-654
    CrossrefPubMedGoogle Scholar
  • 86 Leman J A, Evans A, Mooi W, MacKie R M. Outcomes and pathological review of a cohort of children with melanoma.  Br J Dermatol. 2005;  152 1321-1323
    CrossrefPubMedGoogle Scholar
  • 87 Barnhill R L. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, ‘Spitzoid melanoma’ and risk assessment.  Mod Pathol. 2006;  19(suppl 2) S21-S33
    CrossrefPubMedGoogle Scholar
  • 88 Gonzalez-Campora R, Galera-Davidson H, Vazquez-Ramirez F J, Diaz-Cano S. Blue nevus: classical types and new related entities. A differential diagnostic review.  Pathol Res Pract. 1994;  190 627-635
    PubMedGoogle Scholar
  • 89 Boni R, Panizzon R, Huch Boni R A, Steinert H, Dummer R. Malignant blue naevus with distant subcutaneous metastasis.  Clin Exp Dermatol. 1996;  21 427-430
    CrossrefPubMedGoogle Scholar
  • 90 Calista D, Schianchi S, Landi C. Malignant blue nevus of the scalp.  Int J Dermatol. 1998;  37 126-127
    CrossrefPubMedGoogle Scholar
  • 91 Hofmann U B, Ogilvie P, Mullges W, Brocker E B, Hamm H. Congenital unilateral speckled lentiginous blue nevi with asymmetric spinal muscular atrophy.  J Am Acad Dermatol. 1998;  39 326-329
    CrossrefPubMedGoogle Scholar
  • 92 Chan H H, Kono T. Nevus of Ota: clinical aspects and management.  Skinmed. 2003;  2 89-96
    PubMedGoogle Scholar
  • 93 Hidano A, Kajima H, Ikeda S, Mizutani H, Miyasato H, Niimura M. Natural history of nevus of Ota.  Arch Dermatol. 1967;  95 187-195
    CrossrefPubMedGoogle Scholar
  • 94 Suh D H, Hwang J H, Lee H S, Youn J I, Kim P M. Clinical features of Ota's naevus in Koreans and its treatment with Q-switched alexandrite laser.  Clin Exp Dermatol. 2000;  25 269-273
    CrossrefPubMedGoogle Scholar

James G.H DinulosM.D. 

Section of Dermatology, Dartmouth-Hitchcock Medical Center

One Medical Center Drive, Lebanon, New Hampshire

      >